Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Arcus Biosciences (RCUS) Tax Provisions: 2021-2024

Historic Tax Provisions for Arcus Biosciences (RCUS) over the last 4 years, with Dec 2024 value amounting to $1.0 million.

  • Arcus Biosciences' Tax Provisions changed negligibly% to $1.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $5.0 million, marking a year-over-year decrease of 16.67%. This contributed to the annual value of $1.0 million for FY2024, which is 83.33% down from last year.
  • Latest data reveals that Arcus Biosciences reported Tax Provisions of $1.0 million as of FY2024, which was down 83.33% from $6.0 million recorded in FY2023.
  • Arcus Biosciences' Tax Provisions' 5-year high stood at $6.0 million during FY2023, with a 5-year trough of $1.0 million in FY2022.
  • For the 3-year period, Arcus Biosciences' Tax Provisions averaged around $2.7 million, with its median value being $1.0 million (2024).
  • Its Tax Provisions has fluctuated over the past 5 years, first skyrocketed by 500.00% in 2023, then slumped by 83.33% in 2024.
  • Yearly analysis of 4 years shows Arcus Biosciences' Tax Provisions stood at $2.0 million in 2021, then crashed by 50.00% to $1.0 million in 2022, then surged by 500.00% to $6.0 million in 2023, then slumped by 83.33% to $1.0 million in 2024.